Behavioral
TRE
TRE is a behavioral intervention with 6 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
BEHAVIORAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
4(67%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
6
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution6 total trials
N/ANon-phased studies
6(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
4
trials recruiting
Total Trials
6
all time
Status Distribution
Active(4)
Completed(2)
Detailed Status
Recruiting4
Completed2
Development Timeline
Analytics
Development Status
Total Trials
6
Active
4
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A6 (100.0%)
Trials by Status
completed233%
recruiting467%
Recent Activity
4 active trials
Showing 5 of 6
completednot_applicable
TREAT to Improve Cardiometabolic Health
NCT04465721
recruitingnot_applicable
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
NCT05332613
recruitingnot_applicable
Time-restricted Eating (TRE) and Protein in Older Adults
NCT07314658
recruitingnot_applicable
Time Restricted Eating for WeIght LoSs MainTenance-2
NCT07190170
recruitingnot_applicable
Time Restricted Eating During Chemotherapy for Breast Cancer
NCT05259410
Clinical Trials (6)
Showing 6 of 6 trials
NCT04465721Not Applicable
TREAT to Improve Cardiometabolic Health
NCT05332613Not Applicable
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease
NCT07314658Not Applicable
Time-restricted Eating (TRE) and Protein in Older Adults
NCT07190170Not Applicable
Time Restricted Eating for WeIght LoSs MainTenance-2
NCT05259410Not Applicable
Time Restricted Eating During Chemotherapy for Breast Cancer
NCT06022887Not Applicable
Time-Restricted Eating and Mindfulness-Based Stress Reduction to Reduce the Risk of Early-Onset Colorectal Cancer
All 6 trials loaded
Drug Details
- Intervention Type
- BEHAVIORAL
- Total Trials
- 6